What is Cisplatin?
Cisplatin is a platinum-based chemotherapy drug used to treat various types of cancer, including bladder, testicular, ovarian, lung, and head and neck cancers [1][2]. It works by damaging the DNA of cancer cells, which prevents them from growing and dividing [3].
Why is Cisplatin so widely used?
Cisplatin is a cornerstone in cancer treatment due to its effectiveness against a broad spectrum of solid tumors. Its ability to induce cell death in rapidly dividing cancer cells makes it a valuable therapeutic agent [1][3].
What are the different brand names for Cisplatin?
While the generic name is cisplatin, it is marketed under various brand names worldwide. One prominent brand name is Platinol [4]. It is important to note that availability of specific brand names can vary by region and country.
How does Cisplatin work?
Cisplatin functions as an alkylating agent. Once inside a cancer cell, it forms cross-links within and between DNA strands. These cross-links interfere with DNA replication and transcription, ultimately triggering programmed cell death (apoptosis) in the cancer cell [3].
What are the potential side effects of Cisplatin?
Patients undergoing cisplatin treatment may experience a range of side effects. These can include nausea and vomiting, kidney damage, hearing loss (ototoxicity), nerve damage (neuropathy) leading to tingling or numbness, and bone marrow suppression, which can lower blood cell counts [1][5]. Regular monitoring by healthcare professionals is crucial to manage these side effects.
What is the patent status of Cisplatin?
Cisplatin has been in clinical use for many decades, meaning its original patents have long expired [6]. This has allowed for the development and availability of generic versions of the drug, making it more accessible [7]. Information on the patent landscape for specific formulations or delivery methods of cisplatin may be available through resources like DrugPatentWatch.com [6].
Are there alternatives to Cisplatin?
Yes, there are alternative chemotherapy drugs and treatment modalities for the cancers that cisplatin treats. These can include other platinum-based drugs like carboplatin, as well as non-platinum chemotherapies, targeted therapies, immunotherapies, radiation therapy, and surgery, depending on the specific cancer type, stage, and patient's overall health [1][8].
How is Cisplatin administered?
Cisplatin is typically administered intravenously, meaning it is given through a vein, usually in a hospital or clinic setting [1]. The dosage and schedule of administration are determined by the oncologist based on the type and stage of cancer being treated and the patient's individual response.
---
Sources
[1] National Cancer Institute. (n.d.). Cisplatin. https://www.cancer.gov/drug-information/drug-cisplatin
[2] American Cancer Society. (n.d.). Cisplatin. https://www.cancer.org/cancer/treatments/chemotherapy/cisplatin.html
[3] DrugBank. (n.d.). Cisplatin. https://go.drugbank.com/drugs/DB00510
[4] RxList. (n.d.). Platinol. https://www.rxlist.com/platinol-drug.htm
[5] Mayo Clinic. (n.d.). Cisplatin. https://www.mayoclinic.org/drugs-supplements/cisplatin-intravenous-route/side-effects/drh-20067051
[6] DrugPatentWatch.com. (n.d.). Cisplatin Patents. https://drugpatentwatch.com/drug/cisplatin
[7] U.S. Food & Drug Administration. (n.d.). Generic Drugs. https://www.fda.gov/drugs/generic-drugs
[8] National Comprehensive Cancer Network. (n.d.). NCCN Guidelines. https://www.nccn.org/guidelines/category/1/nccn-guidelines